According to Seelos Therapeutics 's latest financial reports the company's current earnings (TTM) are -$37 M. an increase over its 2022 earnings that were of -$73.52 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$37 M | -49.67% |
2022 | -$73.52 M | 14.07% |
2021 | -$64.45 M | 240.34% |
2020 | -$18.94 M | -62.76% |
2019 | -$50.86 M | 587.73% |
2018 | -$7.4 M | -36.54% |
2017 | -$11.66 M | 74.83% |
2016 | -$6.67 M | -63.26% |
2015 | -$18.14 M | -18.06% |
2014 | -$22.14 M | 46.19% |
2013 | -$15.15 M | -31.67% |
2012 | -$22.17 M | |
2010 | -$20.77 M | 448.63% |
2009 | -$3.79 M | -25.83% |
2008 | -$5.11 M | -45.65% |
2007 | -$9.39 M | 2.82% |
2006 | -$9.13 M | -41.86% |
2005 | -$15.71 M | -9.27% |
2004 | -$17.31 M | 114.92% |
2003 | -$8.06 M | -70.78% |
2002 | -$27.57 M | 60.2% |
2001 | -$17.21 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 199.41% | ๐บ๐ธ USA |